Glimepiride Tablets 4mg
GLIMEPIRIDE is indicated for the treatment of type 2 diabetes mellitus, in which blood glucose concentrations cannot be adequately controlled with diet, physical exercise, and weight reduction. GLIMEPIRIDE can be combined with other non-beta-cellotropic oral antidiabetic agents and can also be administered along with insulin. GLIMEPIRIDE is not appropriate for the treatment of type 1 diabetes mellitus (e.g., for the treatment of diabetic patients with a history of ketoacidosis or diabetic coma).
Pharmaceutical form
Concentration
Combination
N/A
Disclaimer: The content of this website is for pharmaceutical industry professionals interested in creating a strategic alliance with Wexford Laboratories. This page may contain information related to health, medical conditions, physical condition and its treatment. The information contained in this site is not to diagnose a health problem and is not a substitute for the advice provided by your doctor. Always consult a doctor when in doubt about a disease and its treatment. The products are subject to the applicable patent and registration laws of each country, and may not be allowed to be registered in some markets.
